89Zr-DFO-huJ591 PET Scan for Prostate Cancer
Recruiting1 awardPhase 1 & 2
New York, New York
This trial is testing a new type of scan to see if it can better detect prostate cancer that has spread, especially to the bones. The scan uses a special substance to highlight cancer cells in the body. Researchers hope this will improve future cancer treatments.
SBRT Boost for Prostate Cancer
Recruiting1 award
Boston, Massachusetts
This trial will compare two types of radiation therapy given to men with prostate cancer. One group will receive the CyberKnife boost in addition to standard treatment, and the other will not. The study will also look at how the different types of radiation therapy affect the quality of life for participants.
Behavioural Intervention
Home-Based Exercise for Prostate Cancer
Recruiting1 award3 criteria
Charlottesville, Virginia
This trial involves two different exercise programs that can be done at home: one using a stationary exercise bike (Arm A) and the other involving walking (Arm B). The study will include 24 patients
Popular Filters
Trials for Prostate Cancer Patients
Imaging Scans for Prostate Cancer
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will study patients with advanced prostate cancer who are undergoing a specific type of therapy at a VA hospital in Los Angeles. The patients will have several imaging scans before and after the therapy to track the
Behavioral Intervention
NLP-Based Feedback for Prostate Cancer
Recruiting1 award
Los Angeles, California
This trial aims to test a new feedback system that uses Natural Language Processing (NLP) in 20 consultations for men diagnosed with prostate cancer. The study will involve patients from the practices of 10
Radioisotope Therapy
177Lu-rhPSMA-10.1 for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Glen Burnie, Maryland
This trial tests a new radioactive treatment for men with advanced prostate cancer that doesn't respond to hormone therapy. The treatment targets and kills cancer cells by delivering radiation directly to them. This new approach has shown promise in extending survival for men with advanced prostate cancer.
Trials for Adenocarcinoma Patients
Imaging Scans for Prostate Cancer
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will study patients with advanced prostate cancer who are undergoing a specific type of therapy at a VA hospital in Los Angeles. The patients will have several imaging scans before and after the therapy to track the
Behavioral Intervention
NLP-Based Feedback for Prostate Cancer
Recruiting1 award
Los Angeles, California
This trial aims to test a new feedback system that uses Natural Language Processing (NLP) in 20 consultations for men diagnosed with prostate cancer. The study will involve patients from the practices of 10
Radioisotope Therapy
177Lu-rhPSMA-10.1 for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Glen Burnie, Maryland
This trial tests a new radioactive treatment for men with advanced prostate cancer that doesn't respond to hormone therapy. The treatment targets and kills cancer cells by delivering radiation directly to them. This new approach has shown promise in extending survival for men with advanced prostate cancer.
Phase 3 Trials
Hormone Therapy
Androgen Ablation Therapy + Chemotherapy for Prostate Cancer
Recruiting2 awardsPhase 3
Anchorage, Alaska
This trial is studying androgen-ablation therapy and docetaxel to see how well they work compared to androgen-ablation therapy alone in treating patients with metastatic prostate cancer.
Hormone Therapy
Hormone Therapy + Radiation for Prostate Cancer
Recruiting2 awardsPhase 3
Sherbrooke, Quebec
This trial would compare the results of two different doses of radiation therapy, given with or without hormone therapy, in order to determine which is more effective in reducing local failure rates.
Trials With No Placebo
Imaging Scans for Prostate Cancer
Recruiting3 awardsPhase 4
Los Angeles, California
This trial will study patients with advanced prostate cancer who are undergoing a specific type of therapy at a VA hospital in Los Angeles. The patients will have several imaging scans before and after the therapy to track the
Behavioral Intervention
NLP-Based Feedback for Prostate Cancer
Recruiting1 award
Los Angeles, California
This trial aims to test a new feedback system that uses Natural Language Processing (NLP) in 20 consultations for men diagnosed with prostate cancer. The study will involve patients from the practices of 10
Radioisotope Therapy
177Lu-rhPSMA-10.1 for Prostate Cancer
Recruiting1 awardPhase 1 & 2
Glen Burnie, Maryland
This trial tests a new radioactive treatment for men with advanced prostate cancer that doesn't respond to hormone therapy. The treatment targets and kills cancer cells by delivering radiation directly to them. This new approach has shown promise in extending survival for men with advanced prostate cancer.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.